NCT03574025

Brief Summary

Each year around 2000 children have a cardiac arrest in the United Kingdom (UK) and approximately one fifth are admitted to Pediatric Intensive Care Unit. Many of these children eventually die and among those who survive, some will be left with brain damage which could affect their quality of life. Currently, it is difficult for doctors to predict how much brain damage there is at an early stage after cardiac arrest and if this will improve in time. NEURO-PACK aims to follow up children 3 months after their cardiac arrest to assess their quality of life and current functional status (has the child returned to usual routine as before cardiac arrest/mild disability, can the child not participate in certain activities as they were before the cardiac arrest/moderate disability, or if the child has near to no mobility/severe disability). Investigators will find this out by using a questionnaire and the research team will telephone patients and their families 3 months after the child's cardiac arrest. This telephone call should take no longer than 30 minutes. This will then be analysed and will help towards constructing a tool which will help doctors to predict which children who have had a cardiac arrest may survive with minimal brain damage.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
6 months until next milestone

First Posted

Study publicly available on registry

June 29, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
Last Updated

June 29, 2018

Status Verified

June 1, 2018

Enrollment Period

1.3 years

First QC Date

October 30, 2017

Last Update Submit

June 27, 2018

Conditions

Keywords

Observational, Paediatric, Cardiac Arrest, PICU,

Outcome Measures

Primary Outcomes (1)

  • Survival with good neurodevelopmental outcome assessed using the Vineland Adaptive Behavioral Score 2nd Edition (VABS-II).

    The VABS-II is a measure of adaptive behavior validated from birth to adulthood. VABS-II standardized score \> 70 is pre-defined as a 'Good outcome'. A score of 70 or less and death is a 'Poor outcome'. The VABS-II outcome score will be used to create a clinical prediction model of neurodevelopmental outcome within one hour of admission to pediatric intensive care for future reference that clinicians can use to predict which children with cardiac arrest may survive with minimal brain damage.

    3 months after date of cardiac arrest

Secondary Outcomes (1)

  • Neurodevelopmental outcome assessed using the Pediatric Cerebral Performance and Category (PCPC) and Pediatric Overall Performance Category Scale (POPC)

    3 months after date of cardiac arrest

Study Arms (1)

Cardiac Arrest Questionnaire

Children who will survive 3 months after Cardiac Arrest

Other: Questionnaire

Interventions

To telephone the patient/family to look into how the patient is doing, moderate/severe brain damage.

Cardiac Arrest Questionnaire

Eligibility Criteria

Age24 Hours - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children aged more than 24 hours and up to their 16th birthday who are admitted to PICU after a cardiac arrest outside of the unit. Patients aged less than 24 hours will not be included as these patients are frequently managed within the neonatal intensive care unit setting. Patients aged 16 years or greater are frequently managed in the UK within the adult intensive care setting. Only patient admitted to a PICU will be eligible.

You may qualify if:

  • Patients aged 24 hours up to 16th birthday
  • Requiring \> 1minute cardiopulmonary resuscitation
  • Admitted to PICU after Out of Hospital Cardiac Arrest or In Hospital Cardiac Arrest
  • Requiring mechanical ventilation at PICU admission
  • Surviving to 3 months follow up.

You may not qualify if:

  • Cardiac arrest occurring within a PICU or NICU (Neonatal Intensive Care Unit)
  • Parent/ guardian or family member unable to understand the telephone questionnaires for outcome assessments in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Birmingham Women and Children's Hospital PICU

Birmingham, West Midlands, B4 6NH, United Kingdom

RECRUITING

Related Publications (1)

  • Scholefield BR, Martin J, Penny-Thomas K, Evans S, Kool M, Parslow R, Feltbower R, Draper ES, Hiley V, Sitch AJ, Kanthimathinathan HK, Morris KP, Smith F; NEUROPACK Investigators for the Paediatric Intensive Care Society-Study Group (PICS-SG). NEUROlogical Prognosis After Cardiac Arrest in Kids (NEUROPACK) study: protocol for a prospective multicentre clinical prediction model derivation and validation study in children after cardiac arrest. BMJ Open. 2020 Sep 25;10(9):e037517. doi: 10.1136/bmjopen-2020-037517.

MeSH Terms

Conditions

Heart Arrest

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Barney Scholefield

    Birmingham Women's and Children's Hospital

    STUDY CHAIR

Central Study Contacts

Barney Scholefield

CONTACT

Kate Penny-Thomas

CONTACT

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2017

First Posted

June 29, 2018

Study Start

January 1, 2018

Primary Completion

May 1, 2019

Study Completion

August 1, 2019

Last Updated

June 29, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

there is no plan to share individual participant data, however, we will be using and sharing data collected as a whole to construct a prediction tool to help clinicians predict the level of brain damage after cardiac arrest occurs.

Locations